# EDGAR Filing Document

**Accession Number:** 0001920938
**File Stem:** 0001420506-25-002517
**Filing Date:** 2025-8
**Character Count:** 30724
**Document Hash:** 081184dc7f8fbdade9c605b566268fb2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001420506-25-002517.hdr.sgml**: 20250827

**ACCESSION NUMBER**: 0001420506-25-002517

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250827

**EFFECTIVENESS DATE**: 20250827

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BRAIDWELL LP
- **CENTRAL INDEX KEY:** 0001920938

**ORGANIZATION NAME:**
- **EIN:** 861247398
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-23075
- **FILM NUMBER:** 251265938

**BUSINESS ADDRESS:**
- **STREET 1:** ONE HARBOR POINT, 2200 ATLANTIC STREET
- **STREET 2:** 4TH FLOOR
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06902
- **BUSINESS PHONE:** 866-453-3929

**MAIL ADDRESS:**
- **STREET 1:** ONE HARBOR POINT, 2200 ATLANTIC STREET
- **STREET 2:** 4TH FLOOR
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06902

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001920938

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** BRAIDWELL LP

**Address:** ONE HARBOR POINT, 2200 ATLANTIC STREET, STAMFORD, CT 06902

**Telephone number:** 866-453-3929

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-23075

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                             | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                        | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Avadel Pharmaceuticals Plc                 | G29687103 | 07/30/2024     | To approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        2776539 |                0 | FOR         |                                  2776539 | FOR                         |  |
| Replimune Group, Inc.                      | 76029N106 | 09/04/2024     | To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         840925 |                0 | FOR         |                                   840925 | FOR                         |  |
| Replimune Group, Inc.                      | 76029N106 | 09/04/2024     | To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of Replimune Group, Inc.'s  named executive officers.                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         840925 |                0 | ONE YEAR    |                                   840925 | FOR                         |  |
| Paragon 28, Inc.                           | 69913P105 | 04/17/2025     | To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger.                                                                            | SECTION 14A SAY-ON-PAY VOTES |         719611 |                0 | AGAINST     |                                   719611 | AGAINST                     |  |
| Inspire Medical Systems, Inc.              | 457730109 | 05/01/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          31876 |                0 | FOR         |                                    31876 | FOR                         |  |
| Intuitive Surgical, Inc.                   | 46120E602 | 05/01/2025     | To approve, by advisory vote, the compensation of the Company's Named Executive Officers.                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          28796 |                0 | FOR         |                                    28796 | FOR                         |  |
| Danaher Corporation                        | 235851102 | 05/06/2025     | To approve on an advisory basis the Company's named executive officer compensation.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         141094 |                0 | FOR         |                                   141094 | FOR                         |  |
| Celcuity Inc.                              | 15102K100 | 05/13/2025     | To approve, by a non-binding and advisory vote, compensation of the named executive officers.                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         493680 |                0 | FOR         |                                   493680 | FOR                         |  |
| Repligen Corporation                       | 759916109 | 05/15/2025     | Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          51281 |                0 | FOR         |                                    51281 | FOR                         |  |
| Krystal Biotech, Inc.                      | 501147102 | 05/16/2025     | Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         288123 |                0 | FOR         |                                   288123 | FOR                         |  |
| Viking Therapeutics, Inc.                  | 92686J106 | 05/20/2025     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         443354 |                0 | AGAINST     |                                   443354 | AGAINST                     |  |
| Align Technology, Inc.                     | 016255101 | 05/21/2025     | Advisory Vote to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         222486 |                0 | FOR         |                                   222486 | FOR                         |  |
| Neurocrine Biosciences, Inc.               | 64125C109 | 05/21/2025     | Advisory vote on the compensation paid to the Company's named executive officers;                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         623378 |                0 | FOR         |                                   623378 | FOR                         |  |
| Thermo Fisher Scientific Inc.              | 883556102 | 05/21/2025     | An advisory vote to approve named executive officer compensation.                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          77464 |                0 | AGAINST     |                                    77464 | AGAINST                     |  |
| Castle Biosciences, Inc.                   | 14843C105 | 05/22/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         365247 |                0 | FOR         |                                   365247 | FOR                         |  |
| Dianthus Therapeutics, Inc.                | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers; and                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          73261 |                0 | AGAINST     |                                    73261 | AGAINST                     |  |
| Maravai Lifesciences Holdings, Inc.        | 56600D107 | 05/22/2025     | To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        6229366 |                0 | AGAINST     |                                  6229366 | AGAINST                     |  |
| Pulmonx Corporation                        | 745848101 | 05/22/2025     | To conduct a non-binding advisory vote to approve our executive compensation.                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         752541 |                0 | FOR         |                                   752541 | FOR                         |  |
| TransMedics Group, Inc.                    | 89377M109 | 05/22/2025     | To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         312947 |                0 | FOR         |                                   312947 | FOR                         |  |
| OrthoPediatrics Corp.                      | 68752L100 | 05/23/2025     | To approve, on an advisory basis, the resolution approving the compensation of our named executive officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         510563 |                0 | FOR         |                                   510563 | FOR                         |  |
| iRhythm Technologies, Inc.                 | 450056106 | 05/28/2025     | To approve, on a non-binding advisory basis, the named executive officer compensation.                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         139759 |                0 | FOR         |                                   139759 | FOR                         |  |
| Penumbra, Inc.                             | 70975L107 | 05/28/2025     | To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement;                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          59328 |                0 | FOR         |                                    59328 | FOR                         |  |
| Glaukos Corporation                        | 377322102 | 05/29/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         327275 |                0 | FOR         |                                   327275 | FOR                         |  |
| Spyre Therapeutics, Inc.                   | 00773J202 | 05/29/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        1139682 |                0 | FOR         |                                  1139682 | FOR                         |  |
| Dyne Therapeutics, Inc.                    | 26818M108 | 05/30/2025     | To vote, on an advisory basis, to approve the compensation of our named executive officers.                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1640030 |                0 | FOR         |                                  1640030 | FOR                         |  |
| Dyne Therapeutics, Inc.                    | 26818M108 | 05/30/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        1640030 |                0 | ONE YEAR    |                                  1640030 | FOR                         |  |
| Day One Biopharmaceuticals, Inc.           | 23954D109 | 06/02/2025     | Approval, on a non-binding advisory basis, of the compensation of our named executive officers.                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        2113323 |                0 | FOR         |                                  2113323 | FOR                         |  |
| Oruka Therapeutics, Inc.                   | 687604108 | 06/02/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        1572426 |                0 | FOR         |                                  1572426 | FOR                         |  |
| Oruka Therapeutics, Inc.                   | 687604108 | 06/02/2025     | To vote, on a non-binding, advisory basis, on the frequency of future advisory votes to approve compensation for our named executive officers.                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        1572426 |                0 | ONE YEAR    |                                  1572426 | FOR                         |  |
| Apellis Pharmaceuticals, Inc.              | 03753U106 | 06/03/2025     | To hold an advisory vote to approve the compensation paid to our named executive officers;                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         916864 |                0 | FOR         |                                   916864 | FOR                         |  |
| Apellis Pharmaceuticals, Inc.              | 03753U106 | 06/03/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers; and                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         916864 |                0 | ONE YEAR    |                                   916864 | FOR                         |  |
| Kiniksa Pharmaceuticals International, plc | G52694109 | 06/03/2025     | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1267130 |                0 | FOR         |                                  1267130 | FOR                         |  |
| Xenon Pharmaceuticals Inc.                 | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers;                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        2461141 |                0 | FOR         |                                  2461141 | FOR                         |  |
| Skye Bioscience, Inc.                      | 83086J200 | 06/06/2025     | Consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.                                            | SECTION 14A SAY-ON-PAY VOTES |         578645 |                0 | AGAINST     |                                   578645 | AGAINST                     |  |
| Skye Bioscience, Inc.                      | 83086J200 | 06/06/2025     | Consider and vote upon, on an advisory basis, whether the stockholder vote to approve the compensation of the named executive officers as required by Section 14A(a)(2) of the Securities Exchange Act of 1934, as amended, should occur every one, two or three years. | SECTION 14A SAY-ON-PAY VOTES |         578645 |                0 | ONE YEAR    |                                   578645 | FOR                         |  |
| Adaptive Biotechnologies Corporation       | 00650F109 | 06/10/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement;                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        1585567 |                0 | FOR         |                                  1585567 | FOR                         |  |
| Ironwood Pharmaceuticals, Inc.             | 46333X108 | 06/10/2025     | Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1679037 |                0 | FOR         |                                  1679037 | FOR                         |  |
| Alphatec Holdings, Inc.                    | 02081G201 | 06/11/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        2826190 |                0 | FOR         |                                  2826190 | FOR                         |  |
| Trevi Therapeutics, Inc.                   | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        1289660 |                0 | FOR         |                                  1289660 | FOR                         |  |
| Trevi Therapeutics, Inc.                   | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to our named executive officers.                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1289660 |                0 | ONE YEAR    |                                  1289660 | FOR                         |  |
| Cullinan Therapeutics, Inc.                | 230031106 | 06/12/2025     | Proposal to vote, on an advisory basis, to approve our named executive officer compensation.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         834651 |                0 | FOR         |                                   834651 | FOR                         |  |
| Cullinan Therapeutics, Inc.                | 230031106 | 06/12/2025     | Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         834651 |                0 | ONE YEAR    |                                   834651 | FOR                         |  |
| Xencor, Inc.                               | 98401F105 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement;                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         662282 |                0 | FOR         |                                   662282 | FOR                         |  |
| Edgewise Therapeutics, Inc.                | 28036F105 | 06/13/2025     | Conduct an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        3587297 |                0 | FOR         |                                  3587297 | FOR                         |  |
| Edgewise Therapeutics, Inc.                | 28036F105 | 06/13/2025     | Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        3587297 |                0 | ONE YEAR    |                                  3587297 | FOR                         |  |
| Apogee Therapeutics, Inc.                  | 03770N101 | 06/17/2025     | Vote on the frequency of future advisory votes to approve our named executive officers compensation.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          97883 |                0 | ONE YEAR    |                                    97883 | FOR                         |  |
| Blueprint Medicines Corporation            | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         445736 |                0 | FOR         |                                   445736 | FOR                         |  |
| Guardant Health, Inc.                      | 40131M109 | 06/18/2025     | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         864187 |                0 | FOR         |                                   864187 | FOR                         |  |
| Harrow, Inc.                               | 415858109 | 06/18/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         424183 |                0 | FOR         |                                   424183 | FOR                         |  |
| Harrow, Inc.                               | 415858109 | 06/18/2025     | To approve, on a non-binding advisory basis, the frequency of a stockholder advisory vote on the compensation of the Company's named executive officers.                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         424183 |                0 | ONE YEAR    |                                   424183 | FOR                         |  |
| Nuvalent, Inc.                             | 670703107 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         421695 |                0 | FOR         |                                   421695 | FOR                         |  |
| Madrigal Pharmaceuticals, Inc.             | 558868105 | 06/20/2025     | Advisory vote to approve executive compensation                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          24925 |                0 | FOR         |                                    24925 | FOR                         |  |
| Madrigal Pharmaceuticals, Inc.             | 558868105 | 06/20/2025     | Advisory vote to approve the frequency of future advisory votes to approve executive compensation                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          24925 |                0 | ONE YEAR    |                                    24925 | FOR                         |  |
| Protagonist Therapeutics, Inc.             | 74366E102 | 06/20/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         107419 |                0 | FOR         |                                   107419 | FOR                         |  |
| Kymera Therapeutics, Inc.                  | 501575104 | 06/25/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers; and                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         392764 |                0 | FOR         |                                   392764 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** BRAIDWELL LP

**By (Signature):** Ken Joseph

**By (Printed Signature):** Ken Joseph

**By (Title):** Chief Compliance Officer

**Date:** 08/27/2025